Our comparison of gene expression in breast cancers and corresponding healthy breast tissue from the same patients revealed that the vitamin C transporter SVCT2 is downregulated in a majority of breast cancer cases from the TCGA dataset. This evidence concerns the gene SLC23A2 and breast cancer.